A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy

Chong Kun Dang

Status and phase: Completed; Phase 4

Conditions: Hypertension

Treatments: Drug: Cantabell Tab; Drug: Candemore Plus Tab

Study type: Interventional

Funder types: Industry

Identifiers

NCT04521023

244HT16025

Details and patient eligibility

About

Phase 4 clinical trial to Evaluate the blood pressure lowering effect of a Candesartan/Hydrochlorothiazide(Candemore Plus Tab) versus Candesartan/Amlodipine(Cantabell Tab) in Hypertensive Patients

Enrollment: 132 patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• over 19 years old
• Agreement with written informed consent
• Hypertensive Patients

Exclusion criteria

• Patients with secondary hypertension
• Participated in other trial within 30 days
• In investigator's judgement

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

132 participants in 2 patient groups

A

Experimental group

Treatment:

Drug: Cantabell Tab

B

Active Comparator group

Treatment:

Drug: Candemore Plus Tab